Source: Contract Pharma

Spear Pharmacueticals: Mayne Pharma Acquires Generic Efudex

Transaction includes a long-term supply agreement with the current US-based manufacturer

Read full article »
Spear Pharmacueticals's Competitors | Spear Pharmacueticals's News | Spear Pharmacueticals's Financials
Stay up-to-date with the latest news on Spear Pharmaceuticals
Est. Annual Revenue
$25-100M
Est. Employees
25-100
CEO Avatar

President

K.L. Spear

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Spear Pharmaceuticals